Should people with chronic liver diseases be vaccinated against COVID-19?

Hepatic impairment in coronavirus disease 2019 (COVID-19) may derive from cholangiocyte damage in the beginning, but not from direct infection of hepatocytes. Chronic liver disease patients co-infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibited overexpression of angi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li-Ping, Zeng, Qing-Hong, Gong, Yuan-Feng, Liang, Fa-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462231/
https://www.ncbi.nlm.nih.gov/pubmed/34621852
http://dx.doi.org/10.12998/wjcc.v9.i26.7959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462231/
https://www.ncbi.nlm.nih.gov/pubmed/34621852
http://dx.doi.org/10.12998/wjcc.v9.i26.7959

Ejemplares similares